Real-world data show reduction in use of urate-lowering therapy among people with type 2 diabetes using SGLT2 inhibitors.

According to the World Health Organisation (WHO), over 350 million people globally suffer from arthritis, and despite ...

Healthcare products provider RHEA Generics is committed to promoting affordable healthcare by offering generic medications ...

Discover the causes, symptoms, and treatment options for gout—a painful form of arthritis predominantly affecting men.

What do you think of when you hear the term ‘patent medicine’? Nostrums, snake oil, or quack medicine, probably. These days, ...

WHEN Thomas Tuchel was unceremoniously sacked by Chelsea he looked for a factory reset. The England boss, 51, found it in ...

Protalix BioTherapeutics, Inc. (NYSE: PLX), a biopharmaceutical company specializing in the development, production, and commercialization of recombinant therapeutic proteins, recently disclosed its ...

SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...

Amgen today announced the presentation of new data across its rare disease portfolio and pipeline at the annual American College of Rheumatology (ACR) Convergence 2024 conference in Washington, D.C., ...

"We are pleased to report that all eight cohorts of our phase I first-in-human study of PRX-115, our recombinant uricase candidate being developed for the treatment of uncontrolled gout, are now ...

Like a fire alarm sending signals to evacuate a smoky building, the immune system has internal guards to help the body sense ...